Reshma Kewalramani, EVP and CMO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 9,384 shares at $219.37 ($2.1M) on 2019-11-25, disclosed to the SEC on 2019-11-26.
Open-market sale of $2.1M VRTX by EVP and CMO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $219.37 | 4,692 | $1.0M | 50.0% |
| 2 | $219.37 | 4,692 | $1.0M | 50.0% |
| Total | $219.37 avg | 9,384 | $2.1M | 100% |
| Filing → |
| VRTX | SELL | 2024-11-12 | $7.8M | — | Filing → |
| VRTX | SELL | 2024-08-01 | $7.7M | — | Filing → |
| VRTX | SELL | 2024-07-24 | $7.6M | — | Filing → |